Anti-CNGA1 antibodies are used in the immunodetection of the protein cyclic nucleotide gated channel subunit alpha 1. In humans, the canonical protein has a reported length of 686 amino acid residues and a mass of 79.1 kDa. Its subcellular localization is in the cell membrane. A member of the Cyclic nucleotide-gated cation channel (TC 1.A.1.5) protein family, CNGA1 is a known subunit of the rod cyclic GMP-gated cation channel, which is involved in the final stage of the phototransduction pathway. Post-translational modifications have been described, including glycosylation. The CNGA1 gene has been associated with the disease, Retinitis pigmentosa. Synonyms for this target antigen include CNCG1, CNG-1, CNG1, RCNC1, RCNCa, RCNCalpha, RP49, and CNCG. CNGA1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some CNGA1 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.